CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways

Biochemical and Biophysical Research Communications

Volumn 354, Issue 2, 2007, Pages 567-573

  Minamizato, Tokutaro ^a,b   Sakamoto, Kei ^a   Liu, Tingjiao ^a,c   Kokubo, Hiroki ^d   Katsube, Ken ichi ^a   Perbal, Bernard ^e   Nakamura, Seiji ^b   Yamaguchi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c DALIAN MEDICAL UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF GENETICS   (Japan)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BMP; CCN3; Hey1; Notch; NOV; Osteoblasts

Indexed keywords

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CYSTEINE RICH PROTEIN 3; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; NOTCH RECEPTOR; OSTEOCALCIN; PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; GENE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEPHROBLASTOMA OVEREXPRESSED GENE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

3T3 CELLS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOBLASTS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRIDAE;

EID: 33846553080     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.029     Document Type: Article

References (26)

1. Rodan G.A., and Harada S. The missing bone. Cell 89 (1997) 677-680
2. Yamaguchi A., Komori T., and Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21 (2000) 393-411
3. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., and Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127 (1994) 1755-1766
4. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., Kahn A.J., Suda T., and Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J. Cell Biol. 113 (1991) 681-687
5. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
6. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Kim H.J., and Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 278 (2003) 34387-34394
7. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., and Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 309 (2003) 689-694
8. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
9. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., and de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
10. Nobta M., Tsukazaki T., Shibata Y., Xin C., Moriishi T., Sakano S., Shindo H., and Yamaguchi A. Critical regulation of bone morphogenetic protein-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J. Biol. Chem. 280 (2005) 15842-15848
11. Sakamoto K., Yamaguchi S., Ando R., Miyawaki A., Kabasawa Y., Takagi M., Li C.L., Perbal B., and Katsube K. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J. Biol. Chem. 277 (2002) 29399-29405
12. Calhabeu F., Lafont J., Le Dreau G., Laurent M., Kazazian C., Schaeffer L., Martinerie C., and Dubois C. NOV/CCN3 impairs muscle cell commitment and differentiation. Exp. Cell Res. 312 (2006) 1876-1889
13. Takigawa M., Nakanishi T., Kubota S., and Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J. Cell Physiol. 194 (2003) 256-266
14. Lafont J., Jacques C., Le Dreau G., Calhabeu F., Thibout H., Dubois C., Berenbaum F., Laurent M., and Martinerie C. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J. Bone Miner. Res. 20 (2005) 2213-2223
15. Nishida T., Nakanishi T., Asano M., Shimo T., and Takigawa M. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell Physiol. 184 (2000) 197-206
16. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., Li X., Luu H.H., Luo J., Montag A.G., Haydon R.C., and He T.C. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279 (2004) 55958-55968
17. Si W., Kang Q., Luu H.H., Park J.K., Luo Q., Song W.X., Jiang W., Luo X., Li X., Yin H., Montag A.G., Haydon R.C., and He T.C. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol. Cell Biol. 26 (2006) 2955-2964
18. Abreu J.G., Ketpura N.I., Reversade B., and De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 4 (2002) 599-604
19. Parisi M.S., Gazzerro E., Rydziel S., and Canalis E. Expression and regulation of CCN genes in murine osteoblasts. Bone 38 (2006) 671-677
20. Kokubo H., Miyagawa-Tomita S., Nakazawa M., Saga Y., and Johnson R.L. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev. Biol. 278 (2005) 301-309
21. Kadowaki A., Tsukazaki T., Hirata K., Shibata Y., Okubo Y., Bessho K., Komori T., Yoshida N., and Yamaguchi A. Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-2 from calvariae of GFP transgenic mice. Bone 34 (2004) 993-1003
22. Hirata K., Tsukazaki T., Kadowaki A., Furukawa K., Shibata Y., Moriishi T., Okubo Y., Bessho K., Komori T., Mizuno A., and Yamaguchi A. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 32 (2003) 502-512
23. Zamurovic N., Cappellen D., Rohner D., and Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J. Biol. Chem. 279 (2004) 37704-37715
24. Tezuka K., Yasuda M., Watanabe N., Morimura N., Kuroda K., Miyatani S., and Hozumi N. Stimulation of osteoblastic cell differentiation by Notch. J. Bone Miner. Res. 17 (2002) 231-239
25. Deregowski V., Gazzerro E., Priest L., Rydziel S., and Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J. Biol. Chem. 281 (2006) 6203-6210
26. Lee J.S., Thomas D.M., Gutierrez G., Carty S.A., Yanagawa S., and Hinds P.W. HES1 cooperates with pRb to activate RUNX2-dependent transcription. J. Bone Miner. Res. 21 (2006) 921-933